Explore more publications!
Technology Center Malta
Got News to Share?

Technology Center Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Center Malta.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 5, 2026

Kodiak to Scale Autonomous Trucking Hardware and Sensor Solution in Strategic Agreement with Bosch
January 5, 2026

Kodiak to Scale Autonomous Trucking Hardware and Sensor Solution in Strategic Agreement with Bosch

Indeterminate GlobeNewswire
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for December 2025 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics
January 5, 2026

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for December 2025 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics

Indeterminate GlobeNewswire
Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för december 2025 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP
January 5, 2026

Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för december 2025 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP

Indeterminate GlobeNewswire
TomTom Orbis Maps to power CARIAD’s Automated Driving systems
January 5, 2026

TomTom Orbis Maps to power CARIAD’s Automated Driving systems

Indeterminate GlobeNewswire
Burning Rock Announces Founder’s Purchase of Its ADSs
January 5, 2026

Burning Rock Announces Founder’s Purchase of Its ADSs

Indeterminate GlobeNewswire
Communiqué de presse : Le médicament Tzield de Sanofi a été accepté pour un examen prioritaire aux États-Unis pour les jeunes enfants atteints de diabète de type 1 de stade 2
January 5, 2026

Communiqué de presse : Le médicament Tzield de Sanofi a été accepté pour un examen prioritaire aux États-Unis pour les jeunes enfants atteints de diabète de type 1 de stade 2

Indeterminate GlobeNewswire
argenx Announces Leadership Transition Marking Next Evolution of Growth
January 5, 2026

argenx Announces Leadership Transition Marking Next Evolution of Growth

Indeterminate GlobeNewswire
SEALSQ C-Suite Visits India to Advance Post-Quantum Semiconductor Personalization Center, Quantum Investments, and Sovereign Space Capabilities
January 5, 2026

SEALSQ C-Suite Visits India to Advance Post-Quantum Semiconductor Personalization Center, Quantum Investments, and Sovereign Space Capabilities

Indeterminate GlobeNewswire
Press Release: Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes
January 5, 2026

Press Release: Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes

Indeterminate GlobeNewswire
HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma
January 5, 2026

HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions